"The FDA approval for the study is anticipated this year. The trial will be a randomised non-inferiority study between standard of care (existing TAVR devices) and DurAVR™ THV."
Wayne Paterson
So this study involved implanting different brands of valves alongside ours. Can someone explain why we do this? Can't we just compare our results with previous results (from other valves)?
"The FDA approval for the study is anticipated this year. The...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.20 |
Change
-0.290(2.32%) |
Mkt cap ! $257.9M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.50 | $11.80 | $396.0K | 32.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 923 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.20 | 1821 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |